About Archivel Technologies

About company

Archivel Technologies has been devoted to developing R & D projects with a clear vocation for innovation, use of leading technology, respect for the environment and public health Currently, Archivel Technologies participates the development of a vaccine to treat turberculosi infected people who have not developed the disease in conjunction with researchers from the Research Institute of the Hospital Universitari Germans Trias i Pujol.